2.3. Clinical medication regimens
Long protocol for pituitary down-regulation of GnRH-a in luteal phase: Diphereline was administered in the middle luteal phase of the previous menstrual cycle (7 days after ovulation) by daily injection of short-acting GnRH-a of 0.1 mg or 0.05 mg until the hypophysial regulation criteria